Carl Dockery
Patrimonio netto: 48 553 $ in data 31/05/2026
Patrimonio netto: 48 553 $ in data 31/05/2026
Mr. Carl C.
Dockery is an Independent Director at Aytu Biopharma, Inc. and a General Partner at Alpha Venture Capital Management LLC.
He is on the Board of Directors at Aytu Biopharma, Inc. Mr. Dockery was previously employed as an Independent Director by CytoDyn, Inc., a Secretary & Director by Crossroads Insurance Co. Ltd., a President by Alpha Advisors LLC, and a Vice President by Gulf Insurance Co. Ltd. He received his undergraduate degree from Southeastern University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/10/2025 | 21.202 ( 0,2% ) | 48 553 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AYTU BIOPHARMA, INC. | Direttore/Membro del Consiglio | 13/04/2016 |
Alpha Venture Capital Management LLC
Alpha Venture Capital Management LLC Investment ManagersFinance Alpha Venture Capital is an active manager which invests in companies located in the United States. It targets companies operating in the fields of biotech, renewable energy, cloud computing, nanotechnology, photonics, alternative fuel vehicles, clean energy and designer pharmaceuticals. It provides financing for later stage capital requirements. | Investitore di Private Equity | 02/02/2011 |
| Società | Posizione | Fine |
|---|---|---|
| CYTODYN INC. | Direttore/Membro del Consiglio | 12/09/2019 |
Crossroads Insurance Co. Ltd. | Direttore/Membro del Consiglio | 01/01/2008 |
Gulf Insurance Co. Ltd. | Corporate Officer/Principal | - |
Alpha Advisors LLC
Alpha Advisors LLC Investment ManagersFinance Alpha Advisors’ investment philosophy embraces asset allocation as the main driver of portfolio returns, and diversification among asset classes and securities as the primary means of managing risk. They seek to determine the most appropriate portfolio allocation for a client given their goals and stated risk tolerance. The firm primarily uses no-load mutual funds which typically holds multiple underlying equity and/or fixed income positions that provide diversification. | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
CytoDyn, Inc.
CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
Alpha Advisors LLC
Alpha Advisors LLC Investment ManagersFinance Alpha Advisors’ investment philosophy embraces asset allocation as the main driver of portfolio returns, and diversification among asset classes and securities as the primary means of managing risk. They seek to determine the most appropriate portfolio allocation for a client given their goals and stated risk tolerance. The firm primarily uses no-load mutual funds which typically holds multiple underlying equity and/or fixed income positions that provide diversification. | Finance |
Southeastern University
Southeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpha Venture Capital Management LLC
Alpha Venture Capital Management LLC Investment ManagersFinance Alpha Venture Capital is an active manager which invests in companies located in the United States. It targets companies operating in the fields of biotech, renewable energy, cloud computing, nanotechnology, photonics, alternative fuel vehicles, clean energy and designer pharmaceuticals. It provides financing for later stage capital requirements. | Finance |
Aytu Biopharma, Inc.
Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Crossroads Insurance Co. Ltd. | |
Gulf Insurance Co. Ltd. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale